Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,750 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
When micron stock just dropped, it sparked questions about the memory market and Micron's long-term roadmap. This gui...
SpaceX is charging toward a historic IPO, aiming for a mid-June pricing and a Nasdaq debut under SPCX. The deal could...
Bitcoin and Ethereum ETFs faced renewed selling pressure as prices struggled to push through key resistance. ETF flow...
Protests ignite in Nairobi as fuel costs surge and a transport strike widens disrupted daily life; schools shift onli...
As traditional bonds yield less in a volatile rate environment, retirees are turning to covered-call ETFs such as JEP...
Geopolitical tensions flare as Iran hints at escalation. The crypto suffers iran threatens mood weighs on Bitcoin and...
A fresh analysis finds the study: bipartisan social security plan to borrow and invest funds would leave taxpayers wi...
A $50,000 retirement target split 50/50 between REIT dividends and stock dividends changes the math. Today, investors...
NVIDIA's latest financing move links chip power to optical connectivity, hinting at a broader AI infrastructure strat...